Fungal lung disease

Area of Science:

• Pediatric Pulmonology
• Medical Mycology
• Infectious Diseases

Background:

• Fungal lung disease in children exhibits unique characteristics across different patient groups, including immunocompetent, immunocompromised, and cystic fibrosis populations.
• Pulmonary mycoses are less common in immunocompetent children, with endemic mycoses and Aspergillomas being the most frequent diagnoses.
• Recent years have seen a rise in filamentous fungi, such as Aspergillus and Scedosporium, isolated from the respiratory secretions of individuals with cystic fibrosis.

Purpose of the Study:

• To review the distinct presentations and increasing prevalence of fungal lung diseases in pediatric populations.
• To highlight the specific challenges posed by fungal infections in immunocompromised children and those with cystic fibrosis.

Main Methods:

• Literature review focusing on pediatric fungal respiratory infections.
• Analysis of prevalence and etiological agents in different pediatric subgroups.
• Synthesis of current understanding regarding risk factors and clinical manifestations.

Main Results:

• Fungal lung diseases manifest differently in immunocompetent, immunocompromised, and cystic fibrosis pediatric patients.
• Filamentous fungi like Aspergillus and Scedosporium are increasingly identified in cystic fibrosis patients.
• Fungal respiratory infections are more frequent and severe in immunocompromised children, including those with malignancies, transplant recipients, and primary immunodeficiencies.

Conclusions:

• Fungal lung infections in children require tailored diagnostic and therapeutic approaches based on immune status and underlying conditions.
• Increased vigilance is necessary for identifying and managing fungal respiratory pathogens, particularly in vulnerable pediatric populations.
• Further research is warranted to understand the evolving epidemiology and optimize treatment strategies for pediatric pulmonary mycoses.